More about

Inflammation

News
December 19, 2023
4 min watch
Save

VIDEO: Pegcetacoplan shows continued benefit in GA, but side effects may be a concern

VIDEO: Pegcetacoplan shows continued benefit in GA, but side effects may be a concern

In this video, Esther M. Bowie, MD, discusses results of the GALE study, presented at the American Academy of Ophthalmology meeting.

News
December 18, 2023
1 min read
Save

Novel, oral RGRN-305 shows promise in hidradenitis suppurativa treatment

Novel, oral RGRN-305 shows promise in hidradenitis suppurativa treatment

RGRN-305 inhibits heat shock protein 90, and this action may modulate inflammation from hidradenitis suppurativa, according to a study.

News
December 04, 2023
4 min read
Save

Q&A: Gamers, digital screen users may be at greater risk for dry eye disease

Q&A: Gamers, digital screen users may be at greater risk for dry eye disease

Prolonged periods of gaming may contribute to the development of dry eye symptoms in young adults, according to a study presented at the 2023 EastWest Eye Care Conference.

News
December 01, 2023
2 min watch
Save

VIDEO: Real-world outcomes comparable for Dextenza vs. conventional topical regimen

VIDEO: Real-world outcomes comparable for Dextenza vs. conventional topical regimen

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Benjamin Xu, MD, reports similar outcomes for patients using Dextenza compared with more conventional treatments after cataract surgery.

News
November 29, 2023
2 min read
Save

Unfiltered traffic-related air pollution linked to increased BP

Unfiltered traffic-related air pollution linked to increased BP

Inhalation of traffic-related air pollution in a car with unfiltered air was linked to a rapid increase in BP, which peaked within 1 hour, a recent study found.

News
November 28, 2023
2 min read
Save

Dupilumab improves lung function, reduces exacerbations in COPD with type 2 inflammation

Dupilumab improves lung function, reduces exacerbations in COPD with type 2 inflammation

Adults with moderate to severe COPD and type 2 inflammation receiving dupilumab vs. placebo had fewer exacerbations and improved lung function at 52 weeks, according to topline results from the phase 3 NOTUS trial.

News
November 27, 2023
1 min read
Save

LAA exclusion system for use in AF during cardiac surgery cleared, launched in US

LAA exclusion system for use in AF during cardiac surgery cleared, launched in US

Medtronic announced the U.S. launch of its left atrial appendage exclusion system for use during cardiac surgery in patients with preoperative atrial fibrillation.

News
November 21, 2023
2 min read
Save

Orismilast shows early efficacy in plaque psoriasis

Orismilast shows early efficacy in plaque psoriasis

The efficacy of orismilast is greater than placebo in patients with moderate to severe psoriasis, according to phase 2b trial results.

News
November 20, 2023
3 min read
Save

Inflammation predicts events more than cholesterol in high-risk statin-intolerant patients

Inflammation predicts events more than cholesterol in high-risk statin-intolerant patients

PHILADELPHIA — In the CLEAR Outcomes cohort of patients with statin intolerance, inflammation predicted risk for CV events and death more strongly than cholesterol, researchers reported at the American Heart Association Scientific Sessions.

News
November 16, 2023
2 min read
Save

Case study indicates potential link between chronic tophaceous gout and hypercalcemia

PHILADELPHIA — Although rare, hypercalcemia should be treated as a potential threat for patients with from severe tophaceous gout, according to a case study presented at the ASN Kidney Week.

View more